Omar Radwan: The experience of
“Future Care” represents a successful model reflecting ability of the Egyptian
financial market to support companies in their different stages of growth

Ayman Bin Khalifa: Transition of
“Future Care” to the main market reflects progress of the company and growing
trust in its performance
The Egyptian Exchange (EGX) rings-the-bell
today celebrating commencement of trading on the shares of Future care for
Medical Industries (FCMI) on the main market. This follows its official
transition from SMEs market, after meeting all the required rules and
regulations. The event marked the attendance of Mr. Omar Radwan, EGX Executive
Chairman; Mr. Mohamed Sabry, EGX Vice Chairman; Dr. Ayman Bin Khalifa, Chairman
of FCMI; and several leaders of EGX and (FCMI) representatives. This step comes after “Future Care
for Medical Industries” successful completion of capital increase in its issued
and paid-up capital by EGP 57.5 million, increasing its market capital from EGP
57,671,796 million to EGP 115,171,796 million. This reflects ability of the
company to benefit from the financial market obtaining the necessary funding to
support its future plans, along with reaching free float percentage of 99.9974%.

During his speech, Omar Radwan
emphasized that “Future Care” represents a successful model reflecting the
ability of the Egyptian financial market to support companies in their
different stages of growth. He pointed out that the experience of this company
is an important example for start-up companies and SMEs on the importance of
benefiting from the financial market to support growth and expansion plans.

EGX Executive Chairman clarified
that the company started initial listing by the end of year 2012, with EGP 4
million capital and only 8 shareholders. It succeeded through several consecutive
capital increases, in addition to adherence to disclosure, governance, and wise
management to increase its capital to more than EGP 115 million.

Radwan pointed out that this growth
extended to cover expansion of ownership base, to include around 4,966
shareholders today. It’s expected that the market capitalization of the company
approach EGP 885.6 million after listing of additional shares according to the
latest closing price. Omar Radwan added that this
achievement clearly reflects the ability of SMEs market to provide a supportive
environment for promising companies growth and qualify them for transition to
the main market, enhancing their ability to expand and develop their businesses
benefiting from the advantages of the financial market. He pointed out that EGX
recently signed cooperation protocol with Micro, Small, Medium Enterprises Development
Agency (MSMEDA) aiming to provide a package of facilities and incentives for
SMEs, encouraging their listing on EGX, supporting their growth plans, and
expanding their businesses range.

From his side, Dr. Ayman bin Khalifa,
CEO of Future Care for Medical Industries, said that success of the company in fully
covering the capital increase and transition to the main market reflects trust
in the company’s performance and its future plans. He highlighted the capability
of the capital market to provide the necessary funding to support plans of
expansion and investment. He added that the company targets directing
its resources during the coming stage to develop and upgrade its factories,
increasing its production capacity, and expanding manufacturing of medical
products and supplies. This supports health care sector and pharmaceutical industries,
besides creating new job opportunities. He pointed out that the continuous
development of the financial market reflects the state’s attention to enhance
role of the market in supporting economy and providing effective financing
channels for companies. He praised the efforts of the government and EGX’s
management in developing the financial market system, enhancing its efficiency
and improving its ability to support companies in funding their investment and expansion
plans. This will help “Future care” in the coming period to achieve its goals: developing
its factories, increasing its production capacity, and expanding its activities,
which accordingly will create new job opportunities and enhance contribution of
the company in the health care sector and medical industries. Listing of future care on the main
market enhances the ability of the company to reach a broader base of investors
and benefit from the available financing tools through the financial market. This
allows supporting capital expansion plans and funding productive investments according
to the needs of the company and its future plans.